Article
Quantitative proteomics in medication‐related osteonecrosis of the jaw: A proof‐of‐concept study
4 Apr 2022
Abstract excerpt
OBJECTIVE: Medication-related osteonecrosis of the jaw (MRONJ) is a paradoxical effect associated with bone-modifying agents (BMAs) and other drugs. Currently, no valuable diagnostic or prognosis biomarkers exist. The goal of this research was to study MRONJ-related salivary proteome. MATERIALS AND METHODS: This case-control aimed to study salivary proteome in MRONJ versus control groups (i) formed from BMAs...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
